Trial Information
The Feasibility and Acceptability of Using the Delphi Screener for Cervical Cytology Testing Among Low Income Women in New York City
Inclusion Criteria:
- Valid Pap smear in last 1-3 months obtained at participating clinic
- 18 years or older
- Self-report being able to read in English and/or Spanish
- Willing to sign informed consent
Exclusion Criteria:
- Used vaginal product (douche, spermicide, antifungal) in last 48 hours
- Last menses started ≤ 4 days prior to enrollment visit
- No uterus / history of hysterectomy
- Self-report currently pregnant
- Self-report currently breastfeeding
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
Outcome Measure:
Outcome Measure: sensitivity, specificity, kappa compared to gold standard
Outcome Time Frame:
cross-sectional
Safety Issue:
No
Principal Investigator
Carolyn Westhoff, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Columbia University
Authority:
United States: Institutional Review Board
Study ID:
AAAD1382
NCT ID:
NCT00702208
Start Date:
September 2008
Completion Date:
January 2010
Related Keywords:
- Cervical Neoplasia
- cervical cytology
- Pap smear
- self-sampling
- abnormal
- normal
- Neoplasms
Name | Location |
Columbia University Presbyterian Hospital |
New York, New York 10032 |